Ogalvibart

SKU HY-145644-1mg Category Tags , ,

This product is currently out of stock and unavailable.

Products Details

Product Description

– Ogalvibart (C-135-LS) is a humanized anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Ogalvibart binds to the spike (S) glycoprotein receptor-binding domain (RBD) of SARS-CoV-2. Ogalvibart in combination with C144LS (1:1 ratio) shows good preventive activity and can effectively block the development of COVID19 in a rhesus monkey disease model[1].

Web ID

– HY-145644

Shipping

– Room temperature

Applications

– COVID-19-anti-virus

Molecular Formula

– N/A

References

– [1]Beddingfield BJ, et al. Effective Prophylaxis of COVID-19 in Rhesus Macaques Using a Combination of Two Parenterally-Administered SARS-CoV-2 Neutralizing Antibodies. Front Cell Infect Microbiol. 2021 Nov 18;11:753444.

CAS Number

– 2599039-60-6

Molecular Weight

– N/A

SMILES

– [Ogalvibart]

Clinical Information

– Phase 3

Research Area

– Infection

Solubility

– 10 mM in DMSO

Target

– SARS-CoV

Pathway

– Anti-infection

Product type

– Inhibitory Antibodies

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=